• Policy
• GC Biopharma’s Livmarli approved as first ALGS Tx in KOR
• by Lee, Hye-Kyung Mar 2, 2023 05:53am

• Company
• Samsung Bioepis fiercely chases Celltrion in biosimilar mkt
• by Kim, Jin-Gu Mar 2, 2023 05:53am

• Company
• Verquvo takes one step toward insurance coverage listing
• by Eo, Yun-Ho Mar 2, 2023 05:53am

• Company
• Daewoong botulinum toxin Nuceiva launched in Germany and Aus
• by Hwang, Jin-joon Mar 2, 2023 05:52am

• Company
• Jardiance vs Forxiga, competition in chronic kidney dz
• by Eo, Yun-Ho Feb 28, 2023 05:53am

• Company
• Last year’s sales of Yuhan Leclaza were 16.1 billion won
• by Chon, Seung-Hyun Feb 28, 2023 05:52am

• Company
• Recordati Korean subsidiary was launched
• by Eo, Yun-Ho Feb 28, 2023 05:52am

• Company
• Monthly sales of OTC Allegra rise 30% on average
• by Jung, Sae-Im Feb 28, 2023 05:52am

• Policy
• Negotiations on the Brukinsa price have begun
• by Lee, Tak-Sun Feb 28, 2023 05:52am

• Company
• Will Tagrisso finally be reimbursed with public support?
• by Eo, Yun-Ho Feb 28, 2023 05:52am